Autonomix Medical Completes Good Laboratory Practice (GLP) Preclinical Study, Marking Key Step Toward FDA Submission
Autonomix Medical, Inc. announced the successful completion of its Good Laboratory Practice (GLP) preclinical study, demonstrating positive safety and performance outcomes for its nerve-targeted treatment platform. This milestone supports upcoming FDA submission efforts and marks significant progress in the company’s development of innovative medic…